Sponsored diagnostic testing programs for Angelman Syndrome
Angelman syndrome is a rare neurogenetic disorder typically caused by loss of function of the maternal UBE3A gene. It is characterized by developmental delay, absent or limited speech, seizures, movement disorders, and a distinctive behavioral profile. Genetic testing is essential for confirming the diagnosis and guiding care and family counseling.
1 program found for Angelman Syndrome
This program provides access to genetic testing for pediatric patients under 18 who present with an unprovoked seizure. The panel evaluates key epilepsy-associated genes to support diagnostic confirmation, inform prognosis, and guide clinical management. Testing is available to eligible patients when ordered by a licensed healthcare provider.
